The critical role of gut-brain signalling in eating behaviour and obesity
Weight-loss medications like semaglutide work through gut-brain nerve pathways, but they don't fix the underlying nerve damage from high-fat diets, suggesting vagus nerve stimulation as an alternative approach.
This Nature Reviews comprehensive article examines how gut-brain vagal signaling controls hunger, satiation, and food preference, with chronic high-fat diets inducing maladaptive hyperphagia through vagal remodeling and impaired GLP-1 sensitivity. GLP-1 receptor agonists (e.g., semaglutide, tirzepatide) work via these pathways but do not repair the underlying neuronal dysfunction, suggesting the vagus nerve as an underexplored therapeutic target for obesity.
What the study was
- Study design
- Review
- Category
- Prevention
- Maturity
- Exploratory
- Journal
- Nature Reviews Gastroenterology & Hepatology
Why it surfaced
High-quality Nature Reviews GLP-1 mechanistic review; identifies vagus nerve as novel obesity treatment target beyond current GLP-1 RA mechanisms; relevant to cardiometabolic watchlist.
A plain-language summary of published research — not medical advice. Talk to a clinician about your own care.